VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
0.4680
+0.1381 (41.86%)
At close: Aug 7, 2026, 4:00 PM EDT
0.4249
-0.0431 (-9.21%)
After-hours: Aug 7, 2026, 7:59 PM EDT
VivoSim Labs Employees
As of March 31, 2026, VivoSim Labs had 15 total employees, including 9 full-time and 6 part-time employees. The number of employees increased by 2 or 15.38% compared to the previous year.
Employees
15
Change (1Y)
2
Growth (1Y)
15.38%
Revenue / Employee
$8,733
Profits / Employee
-$922,867
Market Cap
1.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 15 | 2 | 15.38% | 9 | 6 |
| Mar 31, 2025 | 13 | -7 | -35.00% | 5 | 8 |
| Mar 31, 2024 | 20 | -4 | -16.67% | 12 | 8 |
| Mar 31, 2023 | 24 | 6 | 33.33% | 15 | 9 |
| Mar 31, 2022 | 18 | 9 | 100.00% | 9 | 9 |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 26 |
| Moleculin Biotech | 17 |
| Genprex | 13 |
| Azitra | 13 |
| Biodexa Pharmaceuticals | 11 |
| Decoy Therapeutics | 11 |
| CDT Equity | 4 |
VIVS News
- 2 days ago - VivoSim regains compliance with Nasdaq - TheFly
- 2 days ago - VivoSim Provides Financial and Listing Compliance Update - GlobeNewsWire
- 8 days ago - VivoSim files to sell 9.41M shares of common stock for holders - TheFly
- 18 days ago - VivoSim enters China with first commercial sales of NAMkind testing services - TheFly
- 18 days ago - VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services - GlobeNewsWire
- 23 days ago - VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor - GlobeNewsWire
- 24 days ago - Why Is Penny Stock VivoSim Labs (VIVS) Up Today? - TipRanks
- 24 days ago - VivoSim receives $5M milestone payment from Eli Lilly - TheFly